Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene

Blood

Volumn 92, Issue 2, 1998, Pages 600-606

  Gutierrez M I ^a,c   Spangler, G ^b   Kingma, D ^a   Raffeid, M ^b   Guerrero, I ^a   Misad, O ^b   Jaffe, E S ^a   Magrath, I T ^b   Bhatia, K ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Maes Heller Cancer Research Centre   (Peru)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER LOCALIZATION; EPSTEIN BARR VIRUS; GENE MUTATION; HOST RESISTANCE; HUMAN; HUMAN TISSUE; LYMPHOMA; NASOPHARYNX CANCER; NOSE CANCER; PRIORITY JOURNAL; VIRUS CARCINOGENESIS;

EID: 2642642956     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.2.600.414k33_600_606     Document Type: Article

References (23)

1. Magrath IT, Jain V, Bhatia K: Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol 3:285, 1992
2. Su IJ, Hsieh HC, Lin KH, Uen VC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY: Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 77:799, 1991
3. Young LS, Dawson CV, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051, 1988
4. Kitano Y, Fujisaki S, Nacamura N, Miyasaki K, Katsuki T, Okamura H: Immunological disorder against the Epstein-Barr virus infection and prognosis in patients with cervical carcinoma. Gynecol Oncol 57:150, 1995
5. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE: Epstein Banvirus in epithelial cell tumors: A breast cancer study. Cancer Res 55:49, 1995
6. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarret RF, Brousset P, Pallesen G, Gulley ML, Khan G, O'Grady J, Hummel M, Preciado MV, Knecht H, Chan JK, Claviez A: Epstein-Barr virus-associated Hodgkin's disease: Epidemiologie characteristics in international data. IntJ Cancer 70:375, 1997
7. Bhatia K, Raj A, Gutiérrez MI, Judde J-G, Spangler G, Venkatesh H, Magrath IT: Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphoma. Oncogene 13:177, 1996
8. Gutiérrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde J-G, Tsao SW, Yuen PW, Joab I, Magrath IT, Bhatia K: Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein Barr virus in normal and tumor cells. J Gen Virol 78:1663, 1997
9. Snudden DK, Smith PR, Lai D, Ng M-H, Griffin BE: Alterations in the structure of the EBV nuclear antigen, EBNA-1, in epithelial cell tumors. Oncogene 10:1545, 1995
10. Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR: Antigenic and sequence variation in the C. terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208:521, 1995
11. Iwakiri D, Nakamura H, Ono Y, Fujiwara S: Antigenic variation of the Epstein-Barr virus nuclear antigen EBNA-I as revealed by monoclonal antibodies. Virus Res 50:139, 1997
12. Molla A, Korneyeva M, Gao Q, Vasasanonda S, Schipper P, Mo HM, Markowitz M, Chernyavsky T, Niu P, Lyons N, Hssu A: Ordered accumulation of mutations in HIV protease confers resistance to Ritonavir. Nat Med 2:760, 1996
13. Duarte EA, Novella IS, Weaver SC, Domingo E, Wain-Hobson S, Clarke DK, Moya A, Elena SF, de la Torre JC, Holland JJ: RNA virus quasispecies: Significance for viral disease and epidemiology. Infect Agents Dis 3:201, 1994
14. Eigen M: The origin of genetic information; viruses as models. Gene 135:37, 1993
15. Gratama JW, Oosterveer MA, Klein G, Ernberg I: EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. J Virol 64:4703, 1990
16. Jaffe E: Nasal and nasal-type T/NK cell lymphoma: A unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 27:581, 1995
17. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peelers C, Falini B, Gatter KC: A revised EuropeanAmerican classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
18. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC: Report of the Workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definition, differential diagnosis and epidemiology. Am J Surg Pathol 20:103, 1996
19. Barletta JM, Kingma DW, Ling Y, Charache P, Mann RB, Ambinder RF: Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probes 7:105, 1993
20. Shibata D, Weiss LM, Nathwani BN, Brynes RK, Levine AM: Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 77:1527, 1991
21. Ho FC, Srivastava G, Loke SL, Fu KH, Leung bP, Liang R, Choy D: Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol 8:271, 1990
22. Gartenhaus RB: Microsatellite instability in hematologie malignancies. Leuk Lymphoma 25:455, 1997
23. Grossberger D, Clough W: Incorporation into DNA of the base analog 2-aminopurine by the Epstein-Barr virus-induced DNA polymerase in vivo and in vitro. Proc Natl Acad Sei USA 78:7271, 1981